A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Development of Sarpogrelate External Preparation for Intractable Pain Control. I. Pre-formulation Study on Application of Modified β-Cyclodextrins
2010
Chemical and pharmaceutical bulletin
To optimize the formulation of in-hospital sarpogrelate (SPG) preparation for external use, various cyclodextrins (CDs) were investigated for their ability to improve the aqueous solubility and chemical stability of SPG. Although hydrolysis of SPG was markedly accelerated at above pH 7.0 in aqueous solution, the addition of modified b b-CD resulted in suppressed SPG hydrolysis. Addition of sulfobutylether-b b-CD (SBE-b b-CD, Captisol ® ) had the most significant stabilization effect. Phase
doi:10.1248/cpb.58.45
pmid:20045965
fatcat:gf3f2ta2nfharajknccdvdlu2m